ZWJ Investment Counsel’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,384
Closed -$390K 293
2017
Q4
$390K Buy
2,384
+640
+37% +$115K 0.03% 191
2017
Q3
$357K Buy
1,744
+158
+10% +$36.7K 0.03% 197
2017
Q2
$386K Sell
1,586
-12
-0.8% -$2.82K 0.03% 194
2017
Q1
$382K Buy
1,598
+55
+4% +$12.8K 0.03% 206
2016
Q4
$324K Hold
1,543
0.03% 128
2016
Q3
$355K Hold
1,543
0.04% 119
2016
Q2
$357K Hold
1,543
0.04% 122
2016
Q1
$414K Hold
1,543
0.04% 115
2015
Q4
$482K Sell
1,543
-500
-24% -$149K 0.05% 109
2015
Q3
$555K Hold
2,043
0.06% 95
2015
Q2
$620K Buy
2,043
+7
+0.3% +$2.09K 0.06% 96
2015
Q1
$606K Buy
2,036
+36
+2% +$10.3K 0.06% 93
2014
Q4
$515K Hold
2,000
0.05% 99
2014
Q3
$483K Hold
2,000
0.05% 103
2014
Q2
$446K Hold
2,000
0.05% 107
2014
Q1
$412K Hold
2,000
0.05% 107
2013
Q4
$336K Hold
2,000
0.04% 115
2013
Q3
$288K Hold
2,000
0.04% 115
2013
Q2
$252K Buy
+2,000
New +$226K 0.03% 117

Other funds holding AGN

ZWJ Investment Counsel's AGN Position: Q1 2018 in Review

ZWJ Investment Counsel sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,384 shares — an estimated $390K sold.

ZWJ Investment Counsel first reported a position in AGN in Q2 2013 and held it in 19 quarters. The position peaked at $620K in Q2 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • ZWJ Investment Counsel reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • ZWJ Investment Counsel sold 2,384 Allergan plc shares in Q1 2018, an estimated $390K.
  • ZWJ Investment Counsel first reported a position in Allergan plc in Q2 2013 and held it in 19 quarters.
  • ZWJ Investment Counsel's Allergan plc position peaked at $620K in Q2 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on ZWJ Investment Counsel's 13F filing for Q1 2018, filed 24 Apr 2018.